IBERCAJA SANIDAD, FI
•CLASE B
Cartera Renta Variable
| 2024-Q4 | ||||
|---|---|---|---|---|
1 | ELI LILLY AND CO | 26.844.393 € | 8.81% | 14.15% |
2 | MERCK & CO INC | 17.187.085 € | 5.64% | 6.38% |
3 | UNITEDHEALTH GROUP INC | 14.414.054 € | 4.73% | 2.79% |
4 | NOVO NORDISK AS CLASS B | 12.446.835 € | 4.09% | 37.93% |
5 | INTUITIVE SURGICAL INC | 11.847.832 € | 3.89% | 21.41% |
6 | ROCHE HOLDING AG | 10.620.317 € | 3.49% | 5.07% |
7 | EDWARDS LIFESCIENCES CORP | 8.938.230 € | 2.93% | 1.27% |
8 | ASTRAZENECA PLC | 8.333.803 € | 2.74% | 33.38% |
9 | JOHNSON & JOHNSON | 8.129.899 € | 2.67% | 2.39% |
10 | MEDTRONIC PLC | 7.979.513 € | 2.62% | 16.26% |
11 | ABBVIE INC | 7.906.646 € | 2.6% | 7.21% |
12 | BECTON DICKINSON & CO | 7.669.709 € | 2.52% | 17.19% |
13 | PFIZER INC | 7.585.125 € | 2.49% | 1.89% |
14 | NOVARTIS AG REGISTERED SHARES | 7.341.068 € | 2.41% | 5.37% |
15 | MERCK KGAA | 7.228.493 € | 2.37% | 9.6% |
16 | BOSTON SCIENTIFIC CORP | 7.074.510 € | 2.32% | 20.02% |
17 | GILEAD SCIENCES INC | 7.012.733 € | 2.3% | 39.31% |
18 | QIAGEN NV | 6.892.150 € | 2.26% | 11.66% |
19 | THERMO FISHER SCIENTIFIC INC | 6.884.141 € | 2.26% | 2.65% |
20 | ELEVANCE HEALTH INC | 6.485.057 € | 2.13% | 49.09% |
21 | ABBOTT LABORATORIES | 5.746.727 € | 1.89% | 12.64% |
22 | AMGEN INC | 5.610.318 € | 1.84% | 13.68% |
23 | DANAHER CORP | 5.099.633 € | 1.67% | 4.93% |
24 | SMITH & NEPHEW PLC | 5.024.939 € | 1.65% | 50.29% |
25 | BRISTOL-MYERS SQUIBB CO | 4.837.620 € | 1.59% | 27.26% |
26 | UCB SA | 4.776.362 € | 1.57% | 8.12% |
27 | SANOFI SA | 4.641.817 € | 1.52% | 4.23% |
28 | LONZA GROUP LTD | 4.566.169 € | 1.5% | 12.1% |
29 | VERTEX PHARMACEUTICALS INC | 4.473.148 € | 1.47% | 11.1% |
30 | SIEMENS HEALTHINEERS AG REGISTERED SHARES | 4.403.200 € | 1.45% | 4.83% |
31 | ESSILORLUXOTTICA | 4.255.878 € | 1.4% | 17.1% |
32 | IQVIA HOLDINGS INC | 3.796.194 € | 1.25% | 3.83% |
33 | ZIMMER BIOMET HOLDINGS INC | 3.775.051 € | 1.24% | 0.71% |
34 | ZOETIS INC CLASS A | 3.619.618 € | 1.19% | 2.75% |
35 | INSULET CORP | 3.599.957 € | 1.18% | 46.58% |
36 | SONOVA HOLDING AG | 3.336.307 € | 1.1% | 9.51% |
37 | BIOGEN INC | 3.138.752 € | 1.03% | 31.74% |
38 | GSK PLC | 3.129.297 € | 1.03% | 9.74% |
39 | AGILENT TECHNOLOGIES INC | 2.660.070 € | 0.87% | 7.24% |
40 | THE CIGNA GROUP | 2.386.919 € | 0.78% | 13.56% |
41 | 武田薬品工業株式会社 | 2.311.103 € | 0.76% | 6.06% |
42 | HCA HEALTHCARE INC | 2.247.139 € | 0.74% | 3.33% |
43 | ILLUMINA INC | 1.814.776 € | 0.6% | 32.47% |
44 | BAXTER INTERNATIONAL INC | 1.340.690 € | 0.44% | 9.79% |
45 | ALCON INC | 1.256.804 € | 0.41% | 1.64% |
| 2025-Q2 | ||||
|---|---|---|---|---|
1 | ELI LILLY AND CO | 23.147.154 € | 8.7% | 13.77% |
2 | INTUITIVE SURGICAL INC | 10.834.084 € | 4.07% | 8.56% |
3 | ROCHE HOLDING AG | 10.790.403 € | 4.06% | 1.6% |
4 | UNITEDHEALTH GROUP INC | 10.719.254 € | 4.03% | 25.63% |
5 | NOVO NORDISK AS CLASS B | 10.705.856 € | 4.02% | 13.99% |
6 | SANOFI SA | 9.332.315 € | 3.51% | 101.05% |
7 | MERCK & CO INC | 8.990.405 € | 3.38% | 47.69% |
8 | EDWARDS LIFESCIENCES CORP | 8.294.095 € | 3.12% | 7.21% |
9 | ASTRAZENECA PLC | 7.763.735 € | 2.92% | 6.84% |
10 | JOHNSON & JOHNSON | 7.542.250 € | 2.83% | 7.23% |
11 | GILEAD SCIENCES INC | 7.393.215 € | 2.78% | 5.43% |
12 | ABBVIE INC | 7.254.251 € | 2.73% | 8.25% |
13 | THERMO FISHER SCIENTIFIC INC | 7.120.575 € | 2.68% | 3.43% |
14 | MEDTRONIC PLC | 6.908.816 € | 2.6% | 13.42% |
15 | BOSTON SCIENTIFIC CORP | 6.879.999 € | 2.59% | 2.75% |
16 | DANAHER CORP | 6.536.065 € | 2.46% | 28.17% |
17 | NOVARTIS AG REGISTERED SHARES | 6.349.307 € | 2.39% | 13.51% |
18 | PFIZER INC | 6.087.249 € | 2.29% | 19.75% |
19 | ABBOTT LABORATORIES | 6.069.505 € | 2.28% | 5.62% |
20 | ELEVANCE HEALTH INC | 6.005.830 € | 2.26% | 7.39% |
21 | MERCK KGAA | 5.683.590 € | 2.14% | 21.37% |
22 | SMITH & NEPHEW PLC | 5.436.103 € | 2.04% | 8.18% |
23 | AMGEN INC | 5.278.862 € | 1.98% | 5.91% |
24 | LONZA GROUP LTD | 4.837.225 € | 1.82% | 5.94% |
25 | QIAGEN NV | 4.729.004 € | 1.78% | 31.39% |
26 | VERTEX PHARMACEUTICALS INC | 4.343.599 € | 1.63% | 2.9% |
27 | SIEMENS HEALTHINEERS AG REGISTERED SHARES | 4.047.160 € | 1.52% | 8.09% |
28 | INSULET CORP | 3.805.238 € | 1.43% | 5.7% |
29 | BRISTOL-MYERS SQUIBB CO | 3.477.543 € | 1.31% | 28.11% |
30 | GSK PLC | 3.112.905 € | 1.17% | 0.52% |
31 | ZOETIS INC CLASS A | 3.043.056 € | 1.14% | 15.93% |
32 | ESSILORLUXOTTICA | 3.042.606 € | 1.14% | 28.51% |
33 | ZIMMER BIOMET HOLDINGS INC | 2.863.129 € | 1.08% | 24.16% |
34 | SONOVA HOLDING AG | 2.674.117 € | 1.01% | 19.85% |
35 | IQVIA HOLDINGS INC | 2.673.963 € | 1% | 29.56% |
36 | THE CIGNA GROUP | 2.509.850 € | 0.94% | 5.15% |
37 | 武田薬品工業株式会社 | 2.354.501 € | 0.88% | 1.88% |
38 | BIOGEN INC | 2.264.179 € | 0.85% | 27.86% |
39 | AGILENT TECHNOLOGIES INC | 2.052.435 € | 0.77% | 22.84% |
40 | HCA HEALTHCARE INC | 1.869.185 € | 0.7% | 16.82% |
41 | BECTON DICKINSON & CO | 1.753.627 € | 0.66% | 77.14% |
42 | BAXTER INTERNATIONAL INC | 1.222.812 € | 0.46% | 8.79% |
43 | ALCON INC | 1.152.596 € | 0.43% | 8.29% |
44 | ILLUMINA INC | 1.138.088 € | 0.43% | 37.29% |
45 | UCB SA | 0 € | Vendida | |
Cartera ICC
| 2024-Q4 | ||||
|---|---|---|---|---|
1 | CANDRIAM EQUITIES L BIOTECHNOLOGY CLASS V USD CAP | 5.635.152 € | 1.85% | 0.6% |
| 2025-Q2 | ||||
|---|---|---|---|---|
1 | CANDRIAM EQUITIES L BIOTECHNOLOGY CLASS V USD CAP | 4.754.612 € | 1.79% | 15.63% |